{
  "url": "https://openlegislation.uk/human-medicines-coronavirus-and-influenza-amendment-regulations-2020-nisr-2020-349/regulation-13",
  "json_url": "https://openlegislation.uk/human-medicines-coronavirus-and-influenza-amendment-regulations-2020-nisr-2020-349/regulation-13.json",
  "legislation": "nisr/2020/349",
  "legislation_title": "The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020",
  "legislation_url": "https://openlegislation.uk/human-medicines-coronavirus-and-influenza-amendment-regulations-2020-nisr-2020-349",
  "path": "regulation/13",
  "kind": "regulation",
  "number": "13",
  "heading": "Amendment of regulation 247",
  "text": "In regulation 247 (exemption for supply in the event or anticipation of pandemic disease), in paragraph (3)(b), for “the symptoms of and” substitute “how the medicinal product is to be used for the prevention of or as a”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "Regulation 247 has been amended by S.I. 2013/235."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/nisr/2020/349/regulation/13",
    "retrieved_at": "2026-10-29T00:40:50.090538+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}